# BioXcel Therapeutics, Inc.: Form 8-K, filed Aug 15, 2025

- Company: [BioXcel Therapeutics, Inc.](/companies/btaiq.md) (CIK 1720893)
- Form: 8-K
- Filed: 2025-08-15
- Accepted by EDGAR: Aug 15, 2025, 09:18 ET
- Period: 2025-08-14
- Accession: 0001104659-25-079042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1720893/000110465925079042/tm2523368d3_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1720893/000110465925079042/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1720893/000110465925079042/tm2523368d3_8k.htm

Filed Aug 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-079042. Last ingested by Listed: Oct 30, 2026, 17:24 ET. No prices; not investment advice.